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doi:10.1016/j.jtcvs.2006.10.009bjectives: Since its introduction in 1987, the Cox-maze procedure has been the
old standard for the surgical treatment of atrial fibrillation. At our institution, this
rocedure has evolved from the cut-and-sew technique (Cox-maze III procedure) to
ne using bipolar radiofrequency energy and cryoablation as ablative sources to
eplace most incisions (Cox-maze IV procedure). This study compared surgical
utcomes of patients undergoing the Cox-maze III procedure versus those of
atients undergoing the Cox-maze IV procedure by using propensity analysis.
ethods: From April 1992 through July 2005, 242 patients underwent the Cox-
aze procedure for atrial fibrillation. Of these, 154 patients had the Cox-maze III
rocedure, and 88 had the Cox-maze IV procedure. Logistic regression analysis was
sed to identify covariates among 7 baseline patient variables. Using the significant
egression coefficients, each patient’s propensity score was calculated, allowing
electively matched subgroups of 58 patients each. Operative outcomes were
nalyzed for differences. Late follow-up was available for 112 (97%) patients.
reedom from atrial fibrillation recurrence and survival was calculated at 1 year by
sing Kaplan-Meier analysis.
esults: The Cox-maze III procedure had significantly longer crossclamp times.
here was no significant difference in intensive care unit and hospital stay, 30-day
ortality, permanent pacemaker placement, early atrial tachyarrhythmias, late
troke, and survival. Freedom from atrial fibrillation recurrence was greater than
0% in both groups at 1 year.
onclusions: The use of bipolar radiofrequency ablation has simplified the Cox-
aze procedure, making it applicable to virtually all patients with atrial fibrillation
ndergoing concomitant cardiac surgery. The Cox-maze IV procedure produces
imilar surgical outcomes to the Cox-maze III procedure at 1 year of follow-up.
trial fibrillation (AF) affects more than 2.2 million persons in the United
States, with an increased incidence within the elderly population.1 The
presence of AF is an independent risk factor for stroke. When compared
ith AF-free patients, there is a 5-fold increase in the incidence of stroke.2 Even
fter adjusting for preexisting cardiovascular conditions, AF is associated with a
.5- to 1.9-fold increase in mortality risk.3 Additional consequences of AF inclu
ncreased hospitalizations, thromboembolic events, hemodynamic compromise, and
ecreased quality of life.4 In addition to the increased patient morbidity 
ortality, AF is associated with significant hospital costs.5
The Cox-maze (CM) procedure was introduced in 1987. It is a set of atrial
ncisions aimed at interrupting the macrore-entrant circuits within the atrial tissue,
hich were believed to be the cause of AF.6 The final iteration of the procedure w
he CM III procedure.7 Although the CM III procedure produced excellent res
nd was considered the gold standard for curing AF,8,9 its technical complexity
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CDrevented it from being incorporated in the daily practice of
he majority of cardiac surgeons.
A variety of energy sources have been used to replace the
ncisions and simplify the CM III procedure, including
nipolar and bipolar radiofrequency (RF), microwave, cryo-
blation, laser, and ultrasonography.10-18 At our institution
ipolar RF ablation was chosen to replace many of the CM
ncisions. Our preference for this energy source was based
n experimental data from our laboratory showing that
ipolar RF always created reliable transmural lesions, had
hort ablation times, and resulted in a focused delivery of
nergy that prevented collateral injury, enhancing the safety
argin of ablation.10-12 Early results in a multicenter tr
howed bipolar RF ablation to safely and effectively elec-
rically isolate atrial tissue.19 This newest version, the C
V procedure, combined bipolar RF ablation and cryo-
blation to replace most of the incisions of the CM III
rocedure. In a small group of 40 patients, this new opera-
ion was found to be simpler and shorter than the CM III
rocedure, with equivalent short-term efficacy.20 However,
o direct comparison of matched patients undergoing the
M IV versus the CM III procedure has been performed.
he objective of this study was to compare the outcomes of
atients undergoing the CM IV procedure with propensity-
atched cohorts from the historical CM III group.
ethods
rom April 1992 through July 2005, 242 patients underwent the
M procedure for AF at Barnes-Jewish Hospital. Of these, 154
atients had the CM III procedure, and 88 had the CM IV proce-
ure. Propensity score analysis was performed to select a matched
ontrol group of patients.
ropensity Score Analysis
he nonrandomness of procedure assignment was addressed by
ropensity matching to provide a more reliable assessment of
utcomes based on procedure type. Logistic regression analysis
as used to identify covariates among 7 baseline patient variables
hat were imbalanced in the 2 groups of interest (SPSS 11.0 for
indows; SPSS Inc, Chicago, Ill). Variables included age, sex,
reoperative left ventricular ejection fraction, New York Heart
ssociation (NYHA) classification, diagnosis of AF (persistent,
ermanent, or paroxysmal AF), duration of AF before surgical
ntervention, and type of operative procedure performed (lone CM,
Abbreviations and Acronyms
AF  atrial fibrillation
CABG  coronary artery bypass graft
CM  Cox-maze
ICU  intensive care unit
NYHA New York Heart Association
RF  radiofrequencyM with a concomitant coronary artery bypass graft [CABG], or a
90 The Journal of Thoracic and Cardiovascular Surgery ● FebrM with a concomitant valve procedure with or without a CABG).
ersistent AF was defined as continuous AF. Permanent AF was
efined as persistent AF of more than a 6-month duration that had
ailed either electrical or chemical cardioversion. Paroxysmal AF
as defined as sinus rhythm with intermittent episodes of AF. By
sing the significant regression coefficients, a propensity score was
alculated for each of the 242 patients who underwent a CM III or
V procedure. The total population was ranked by propensity
core, and the patients were closely matched on the basis of this
core. The short- and long-term outcomes of the patients were
linded during the matching process. Resulting matched patients
ere analyzed for differences in selected early and late outcomes:
rossclamp time, cardiopulmonary bypass time, intensive care unit
ICU) length of stay, hospital length of stay, 30-day operative
ortality, postoperative permanent pacemaker placement, inci-
ence of early tachyarrhythmias, late stroke, survival, and late
ecurrence of AF.
urgical Technique
he surgical procedure for the CM III procedure has previously
een described in detail.21 Most patients underwent a medi
ternotomy and cardiopulmonary bypass with bicaval cannulation.
n the beating heart, right atrial incisions included excision of the
ight atrial appendage, followed by a free wall incision, a linear
ncision from the orifice of the superior vena cava to the orifice of
he inferior vena cava, and a perpendicular, or T, incision to the
evel of the tricuspid valve annulus. A second incision to the
ricuspid annulus was made from the right atrial appendage. At the
ricuspid annulus, a 3-mm cryoprobe (Frigitronics CCS200, Trum-
ell, Conn) was applied.
The heart was arrested, and access to the left atrium was
hrough a standard left atriotomy with amputation of the left atrial
ppendage. The remaining left atrial incisions included an atrial
eptal incision and encirclement of the pulmonary veins with
xtension to the mitral valve annulus. A cryoprobe was used
etween the appendage amputation site and the 2 ends of the
ulmonary vein encircling the incision, as well as over the coro-
ary sinus, and at the mitral valve annulus.
The bipolar RF system consisted of the ablation-sensing unit
nd the Atricure Isolator (n  57; Atricure, Inc, Cincinnati, Ohio)
r the Medtronic Cardioblate BP Surgical Ablation System (n 1;
edtronic, Inc, Minneapolis, Minn). For the Atricure device, the
nergy was applied at 75 W and 750 mA between the jaws of the
nstrument. The generator continuously monitored voltage, cur-
ent, temperature, and conductance. Tissue temperature was mea-
ured 1 mm from the electrode edge. Two seconds after conduc-
ance decreased to less than 0.025 siemens, an indicator light
ashed, and an audible tone was heard, signifying full-thickness
oagulation and termination of the ablation. Total ablation time
nd maximum tissue temperature were recorded for every lesion.
The Medtronic irrigated bipolar RF surgical ablation device
onsisted of a hand piece with embedded electrodes and an RF
enerator. The device was irrigated with saline solution to improve
onduction of the delivered energy. The RF generator continuously
onitored tissue impedance, current, voltage delivered, and the
uration of ablation. Tissue was considered fully ablated when
mpedance reached a stable plateau. Initially, moderate power was
pplied to the tissue. The derivative of impedance (dZ/dt) was
uary 2007
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CDalculated every 200 ms. When impedance achieved a stable
lateau, the power was increased by a step function of 5 W. If the
lateau in impedance was not sustained, then the algorithm deter-
ined that transmurality had not been achieved, and ablation
ontinued until another plateau in impedance was detected. This
rocess was repeated until an impedance plateau was sustained
fter an increase in power. When this end point was reached, the
icroprocessor determined that transmurality had been achieved,
nd a signal was provided to the user.
The CM IV procedure differed from the CM III procedure
ecause it isolated the right and left pulmonary veins as 2 islands,
reserved the right atrial appendage, and in some cases left the
osterior left atrium in electrical continuity with the remaining
trium.22 After either median sternotomy or right thoracotom
atients underwent a pericardiotomy and were started on cardio-
ulmonary bypass. If patients were not in normal sinus rhythm,
ntraoperative direct-current cardioversion was performed. Before the
blation procedure, the pacing threshold was recorded from the pul-
onary veins. Bipolar RF ablations were completed around the right
nd the left pulmonary veins. After ablation, electrical isolation was
onfirmed by means of bipolar pacing at 20 mA from both the
uperior and inferior pulmonary veins. If atrial capture was present,
he ablation was repeated until electrical isolation was achieved. The
emainder of the operation has been described in a prior publicat23
In summary, the right-sided lesions were created by making a
imple atriotomy that extended from the intra-atrial septum to near
he atrioventricular groove at the acute margin of the heart (Figu
ll the other incisions of the traditional cut-and-sew method were
eplaced with bipolar RF ablation lines. Two cryolesions were
laced at the tricuspid annulus by using a linear cryoprobe. The
eft-sided lesions involved only a simple atriotomy extending onto
he dome of the left atrium and inferiorly around the orifice of the
ight inferior pulmonary vein. It intersected the encircling right
ulmonary vein ablation. A connecting lesion was performed from
he inferior aspect of the left atrium into the left inferior pulmonary
ein. In atria larger than 5 cm in diameter, a second connecting
esion was placed from the superior aspect of the incision into the
eft superior pulmonary vein. A bipolar RF ablation line was
erformed from the inferior end of the incision down to the mitral
nnulus. A final cryolesion was placed at the mitral annulus with
15-mm bell probe. The left atrial appendage was amputated, and a
nal bipolar RF ablation was performed between the left atrial
ppendage and the left superior pulmonary vein.
ostoperative Care and Follow-up
fter the operation, all patients were monitored continuously for
rrhythmias. Patients were started prophylactically on antiarrhyth-
ic drugs, unless they were in heart block or junctional rhythm.
he drug of choice was amiodarone, which was continued for the
rst 2 or 3 months postoperatively and then was discontinued if the
atient was in normal sinus rhythm. If patients experienced post-
perative atrial tachyarrhythmias, they were cardioverted between
to 4 weeks after the procedure. Unless there was a contraindi-
ation, all patients were anticoagulated with warfarin for the first
months, at which point it was discontinued if the patient was in
ormal sinus rhythm.
Follow-up for the patients in the CM III group consisted of aetrospective cross-sectional analysis performed in 2001. This a
The Journal of Thoracic).
ncluded a mailed questionnaire or telephone interview, as well as
ontact with either their cardiologist or primary care physician
egarding recurrence of AF. In patients who complained of ar-
hythmia recurrence, copies of an electrocardiogram and Holter
onitoring were obtained. Patients in the CM IV group were
ollowed prospectively and had visits scheduled for 1, 3, 6, and 12
onths postoperatively. Patients were then followed annually. At
ll follow-up visits, a history, physical examination, and electro-
ardiogram were obtained. For patients who could not return to our
nstitution, telephone questionnaires were performed, and electro-
ardiograms were obtained from referring physicians to document
he heart rhythm. In patients with symptoms of palpitations, an
lectrocardiogram or prolonged Holter recording (24 hours) was
btained to assess their rhythm status.
Recurrence of AF was documented if a patient required a
ardioversion or atrial ablation greater than 3 months after the
rocedure or the presence of AF was seen on prolonged Holter
onitoring or electrocardiography. Any episode of recurrent AF
fter 3 months was classified as a permanent failure.
ata Analysis
ata were represented as frequency distributions and percentages.
ll continuous data were expressed as means  standard devia-
ion. Categoric data were expressed as counts and proportions.
omparisons were done with paired, 2-tailed t tests for means of
ormally distributed continuous variables and the Wilcoxon rank
um test for skewed data. Fisher exact or 2 tests were used to
nalyze differences among the categoric data. Freedom from AF
ecurrence and survival was calculated at 1 year by using Kaplan-
eier analysis. Statistical analysis of data was conducted with the
PSS system for statistics (SPSS 11.0 for Windows, SPSS Inc).
esults
atient Demographics
ive variables were not significant in the logistic regression
igure 1. Cox-maze IV procedure lesion set. Lt. Appendage, Left
trial appendage; SVC, superior vena cava; Rt. Appendage, right
trial appendage; IVC, inferior vena cava; Rt. Coronary Artery,
ight coronary artery.nalysis in predicting group assignment, including sex, pre-
and Cardiovascular Surgery ● Volume 133, Number 2 391
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A
CDperative left ventricular ejection fraction, diagnosis of AF
persistent, permanent, or paroxysmal AF), duration of AF
efore surgical intervention, and type of operative proce-
ure performed (lone CM, CM with a concomitant CABG,
r CM with a concomitant valve procedure plus or minus a
ABG). In contrast, the logistic regression analysis identi-
ed 2 variables, older age and a higher NYHA classifica-
ion, as significant predictors for the performance of a CM
V procedure.
This process matched 58 of the 154 patients who under-
ent a CM III procedure with 58 of the 88 patients who
nderwent a CM IV procedure. Thirty of the 88 patients in
he CM IV group were not able to be matched with the
atients in the CM III group because their propensity scores
ere extreme outliers.
Selected preoperative patient characteristics for the CM
II and CM IV groups are listed in Table 1. There w
ignificant difference between the 2 groups in age, sex, left
entricular ejection fraction, preoperative diagnosis (persis-
ent, permanent, or paroxysmal AF), preoperative AF dura-
ion, operative procedure (lone CM, CM with concomitant
ABG, or CM with concomitant valve and CABG), or
YHA classification. Late follow-up was available for 112
97%) patients. Late follow-up was 100% in the CM IV
able 1. Preoperative clinical characteristics of the
ropensity-matched cut-and-sew (CM III) versus ablation-
ssisted (CM IV) groups
haracteristic CM III CM IV
o. of patients 58 58
ge, mean SD (y) 58  11 60 11
ale sex 34 (60%) 37 (63%)
eft ventricular ejection fraction,
mean  SD
52  10 48 14
reoperative diagnosis
Persistent AF 1 (2%) 1 (2%)
Permanent AF (6 mo) 29 (50%) 22 (38%)
Paroxysmal AF 28 (47%) 35 (61%)
reoperative atrial fibrillation
duration, mean  SD (y)
7.3  7.0 7.1 8.2
perative procedure
Lone Cox-maze 28 (49%) 29 (51%)
Cox-maze, concomitant CABG 14 (25%) 8 (14%)
Cox-maze, concomitant
valve CABG
16 (26%) 21 (36%)
YHA classification
Class I 17 (30%) 19 (32%)
Class II 26 (44%) 20 (34%)
Class III 11 (19%) 15 (27%)
Class IV 4 (7%) 4 (7%)
M III, Cox-maze III procedure; CM IV, Cox-maze IV procedure; SD,
tandard deviation; AF, atrial fibrillation; CABG, coronary artery bypass
raft; NYHA, New York Heart Association.roup and 93% in the CM III group. Mean follow-up was w
92 The Journal of Thoracic and Cardiovascular Surgery ● Febrno
ignificantly longer in the CM III group (4.3  2.7 years)
ersus that in the CM IV group (1.2  0.8 years). Median
ollow-up was 5.1 years and 1.1 years in the CM III and CM
V groups, respectively.
arly and Late Outcomes
arly and late outcomes are summarized in Table 2.
M III group had significantly longer crossclamp times
P  .001) than the CM IV group. There was no significant
ifference in ICU or hospital stay, 30-day mortality, perma-
ent pacemaker placement, early atrial tachyarrhythmias, or
ate stroke. There was 1 perioperative stroke in the CM IV
roup and none in the CM III group. There was 1 death in
he CM III group caused by multisystem organ failure. The
deaths in the CM IV group were due to the following:
ulmonary embolism; hepatic failure, sepsis, and heparin-
nduced thrombocytopenia; and late postoperative tampon-
de and renal failure.
Survival at 1 year, as determined by means of Kaplan–
eier analysis, was 94% in the CM III group and 89% in
he CM IV group (P  .19). Freedom from AF recurrence
t 3 and 6 months was 98% in each group. Freedom from
F recurrence at 1 year was 96% and 93% in the CM III and
M IV groups, respectively (P  .52), as determined by
sing Kaplan–Meier analysis (Figure 2). Antiarrhythm
rug use at last follow-up was 19% in the CM III group and
1% in the CM IV group. However, no statistical compar-
son was made because of the major difference in follow-up
ata collection of this variable between groups.
iscussion
he CM procedure originally was developed to control the
ymptoms and sequelae of AF.6 It consisted of a compl
et of incisions designed to prevent macrore-entrant circuits
rom forming in the atria, which was the prominent theory
t that time regarding the mechanism of AF.6,24,25 The CM
rocedure was difficult, required long crossclamp times, and
able 2. Early and late outcomes of the propensity matched
ut-and-sew (CM III) versus ablation-assisted (CM IV)
roups
ariable CM III CM IV P value
ean crossclamp time (min) 121 34 76 37 .001
edian intensive care unit stay (d) 2 2 .97
edian hospital stay (d) 10 9 .77
acemaker placement 9 (16%) 6 (10%) .42
arly atrial tachyarrhythmias 27 (47%) 36 (61%) .19
0-day mortality 1 (2%) 3 (5%) .62
reedom from atrial fibrillation* 96% 93% .52
ate stroke 0% 0% 1.00
M III, Cox-maze III procedure; CM IV, Cox-maze IV procedure. *Kaplan-
eier analysis at 1 year.as associated with significant morbitiy.9 Its technical com-
uary 2007
p
w
e
r
e
l
i
a f
t
w
R
s ith
b
c
c
o
m
t m
p
p
d
b
c
C
i
e
t
t
d
f
e
f
p
s
i
c
t
p
m
r
c
b
a
t
u
I
a
p
s
a
m
t
a ions
c
S
m l
m
l
d
a
d
w
p
I
t
a
f
t
I
d
n
t
p
a
p
c
p
l
t
T
T
p
p
u
a
t
I
o
l
i
d
f
s
t
a
Lall et al Surgery for Acquired Cardiovascular Disease
A
CDlexity prevented the CM procedure from being adopted
idely by cardiac surgeons.
Over the past decade, a number of alternatives have been
xamined to simplify the surgical treatment of AF and
educe the associated morbidity. A central strategy of these
fforts has been to replace the surgical incisions with linear
ines of ablation by using a variety of energy sources,
ncluding unipolar and bipolar RF, microwave, cryo-
blation, laser, and ultrasonography.10-17 Although all o
hese have enjoyed some degree of success, experimental
ork by our laboratory and others have revealed that bipolar
F ablation resulted in the most consistent transmural le-
ions.10-13 Moreover, lesions were quicker to perform w
ipolar RF than other energy sources. The injury also was
ontained within the jaws of the clamp, preventing the
ollateral damage seen with other unipolar devices.26-28 At
ur institution, this energy source was adopted to replace the
ajority of the CM incisions, and the procedure was termed
he CM IV procedure.20 Early and late events were co-
ared between the 2 groups to determine whether this new
rocedure produced similar outcomes as the CM III proce-
ure. A propensity analysis was used to overcome selection
ias.
In these matched patients the CM III group had signifi-
antly longer crossclamp times when compared with the
M IV group. Bipolar RF ablation replacing the surgical
ncisions simplified the procedure, allowing for shorter op-
rative times in the CM IV group. The use of this ablation
echnology removed the major obstacle to widespread adop-
ion of the CM procedure, its complexity and technical
ifficulty. This has significantly altered our own indication
or AF operations in patients with concomitant heart dis-
ase. Although in the past the CM procedure was reserved
or highly selected patients, it is now offered to virtually all
atients with chronic AF referred for valvular or coronary
urgery. This change in attitude is testified to by the fact that
t took 9.2 years to accumulate the 58 patients in the CM III
ohort compared with 3.2 years for the CM IV cohort.
Other outcomes were not significantly different between
he 2 groups. ICU and hospital stay, 30-day mortality,
ermanent pacemaker placement, and atrial tachyarrhyth-
ias and late stoke were similar. Thus the CM IV procedure
esulted in similar operative outcomes with a shorter cross-
lamp time.
There was no difference in freedom from AF recurrence
etween the 2 groups on the basis of Kaplan–Meier analysis
t 1 year. Both procedures yielded success rates of greater
han 90%. This agrees with a prior report involving an
nmatched comparison of 30 patients who underwent a CM
II procedure with 40 patients undergoing a modified RF
blation maze procedure.29
A major difference between the CM III and CM IV
rocedures is the method of creating the lesions (cut-and- s
The Journal of Thoracicew vs ablation). An incision creates a conduction block
cross the suture line 100% of the time. Although experi-
ental studies have shown the ability to isolate targeted
issue and produce transmural lesions using the bipolar RF
blation device,10-13 it is possible that not all the les
linically produced conduction block or were transmural.
tudies have shown that gaps as small as or smaller than 1
m can allow the propagation of AF.30 Isolation of the pu-
onary veins can be tested intraoperatively, but the remaining
esions cannot be verified. Furthermore, in the CM IV proce-
ure less left atrial tissue is isolated, leaving more of the left
trium in electrical continuity. Further follow-up is needed to
etermine whether these small differences between procedures
ill have any late effect at greater than 1 year.
Antiarrhythmic drug use was different between the study
opulations at last follow-up. Although the data for the CM
V group at 1 year were available, postoperative data from
he CM III group were collected in a cross-sectional manner
nd did not allow for analysis at 1 year but rather only at last
ollow-up. The median follow-up was quite different be-
ween the 2 groups, making it difficult to compare the CM
II and CM IV groups in terms of need for antiarrhythmic
rugs.
The limitations of this study included the relatively small
umber of patients in each group. However, with 116 pa-
ients, this series is the largest comparison of matched
atients undergoing a cut-and-sew versus an ablation-
ssisted CM procedure in the literature. Moreover, with no
rospective randomized studies either published or in pro-
ess, this might be the most valid way to compare these 2
rocedures.
The CM III patient information was retrospectively col-
ected, whereas CM IV patient information was prospec-
ively collected, and follow-up has been more complete.
his might have contributed to the slightly higher failure rate.
he CM IV procedure was more widely applied to higher-risk
atients than the CM III procedure, making retrospective com-
arison difficult. For this reason, the propensity analysis was
sed to help overcome this shortcoming.
An additional weakness of this study is the means of
ssessing recurrence of AF. In the CM IV group an elec-
rocardiogram was obtained at each follow-up appointment.
f a patient in either the CM III or CM IV group complained
f symptoms of palpitations, an electrocardiogram or pro-
onged Holter monitoring was obtained. If patients had
mplanted pacemakers, these were interrogated and used to
etermine the occurrence of AF. These limitations of
ollow-up were similar to all previous reports, and one
trength of this study was the low percentage of patients lost
o follow-up.
In summary, the CM IV procedure, using bipolar RF
blation, has simplified the procedure from a technical
tandpoint, making it applicable to most patients with
and Cardiovascular Surgery ● Volume 133, Number 2 393
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A
CDF undergoing concomitant cardiac surgery. Comparing
atched populations, the operation can be done with a
horter crossclamp time and produces similar surgical out-
omes to the cut-and-sew technique of the original CM
rocedure.
The authors gratefully acknowledge the contributions of Bryan
. Meyers, MD, and Richard B. Schuessler, PhD, in the statistical
nalysis of our data.
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CDiscussion
r W. Randolph Chitwood (Greenville, NC). Thank you, Dr
itchell. I rise first to congratulate Dr Damiano, Dr Lall, and their
ssociates for collating, analyzing and presenting these important
ata. Dr Lall, your presentation was absolutely excellent. I re-
iewed the manuscript in detail in advance and have several
omments and a few questions.
Clearly, Dr Jim Cox established the gold standard for a proce-
ure to relieve patients of AF, both intermittent and continuous
F. The seminal investigative and clinical work of Dr Cox and Dr
onieau at Washington University eventuated in the CM III pro-
edure, which was described first in the Journal of Cardiothoracic
nd Vascular Surgery in 1995, also bears mention. Through de-
ailed intraoperative mapping, he finally settled on an effective
ight and left atrial incision set that relieved more than 95% of
atients from AF. New lesion sets in the CM III procedure at that
ime improved both right and left atrial transport and decreased the
eed for pacemakers. Despite these impressive results, the com-
lexity of creating surgical lesions and the morbidity, especially in
nexperienced hands, precluded the widespread adoption of the
M III procedure, despite these obvious advantages that Dr Lall
as shown us. This is especially true when combined with mitral
alve surgery and mitral valve repair.
Dr Damiano’s work has continued in this illustrious shadow,
ith attempts to determine an effective operative method that most
urgeons can perform in a reasonable time with minimal compli-
ations. The procedure described in this presentation used bipolar
F ablation, with most lesions approximating those of the CM III
rocedure. However, there were differences in the lesion sets.
The authors have compared 154 patients undergoing traditional
ut-and-sew operations with 88 patients undergoing the new op-
ration, which has been dubbed here as the CM IV procedure.
ecause a serial patient series was reviewed retrospectively, the
uthors used a propensity score analysis to select matched cohorts
or comparison. This method yielded 58 patients in the cut-and-
ew group and 58 patients in the bipolar RF or CM IV group.
atients had either lone AF, or it was combined with valvular or
oronary disease, and therefore they really were not all the same.
hey determined that more than 90% in both groups were relieved
f AF, suggesting that this new method could supersede the
raditional operation as a standard. There was no statistical differ-
nce between the groups as far as relief from AF. In the CM IV
roup 12% more patients continue to receive antiarrhythmics, but
ollow-up was 4 years less than in the CM III group.
A weakness of this study, of course, is the retrospective review,
hich we are all forced to do, and the small number of patients in
ach final comparative cohort. However, these seem inescapable
onsidering the evolutionary nature of these methods.
Our results confirm the data presented. In an attempt to render
n effective, minimally invasive, small-incision AF operation, we
eveloped an endoscopic method using cryoablative lesions at
150°C. In 161 patients either with lone AF or combined with
itral valve disease, we approximated the lesion set described by
r Lall. Of the 41 patients with lone AF, either intermittent or
ontinuous, 92% were AF free 3 months without drugs and 2
ontinued to receive antiarrhythmics, suggesting that a full lesion
et, as you suggested, is optimal and that these operations are safe
nd efficient. We had no mortality in the lone AF group, and 13% d
The Journal of Thoracicequired pacemakers, as you have shown here. I have several
uestions for you.
This commentator applauds you for confirming electrical iso-
ation of pulmonary veins by pacing and mapping for exit block. I
hink this is important. Would it have been possible to determine
solation of the right side and other parts of the right atrium? Does
t matter if we isolate the right atrium? Why do the right side at all
f there is no AF?
Would you like me to go ahead and ask all my questions, or let
er answer them one at a time?
Dr Mitchell. Let’s go one at a time.
Dr Lall. Thank you, Dr Chitwood, for your kind comments and
uestions. It is an honor to have you discuss our article, and we
ecognize the many achievements of your group in pioneering
inimally invasive AF surgery.
To address your first question on confirmation of conduction
lock, we can use computerized mapping techniques and multiple
lectrodes to confirm conduction block, but this is difficult to do in
he operative setting; it is very time consuming and not practical.
he other way to confirm isolation is with pacing or recording of
ndividual electrocardiograms. This would require a portion of the
trium to be completely electrically isolated from the remainder of
he atrium, and in the CM lesion sets, this only occurs around the
ulmonary veins.
In terms of the right atrial lesions, we do believe that it is
mportant to perform a biatrial lesion set because mapping studies
ave shown that between 10% and 30% of patients with AF have
right atrial focus.
Dr Khargi, in the Journal of European Cardiothoracic Surgery
n 2005, showed in a univariate analysis that sinus rhythm con-
ersion rates were higher in the biatrial lesion set group, and also
r Niv Ad has shown this in a meta-analysis. Finally, without any
ight atrial lesions, there will be an incidence of late atrial flutter of
bout 10% to 20% in most series.
Dr Chitwood. Therefore you are suggesting we always do the
ight side.
What is the rationale for isolating the pulmonary veins in 2
slands rather than as 1 continual island?
Dr Lall. The bipolar clamp device that we use makes it
mpossible to encircle all 4 pulmonary veins at once. Therefore we
solate the right and left pulmonary veins separately, and then a
esion across the inferior posterior left atrium is completed. In
atients with an atrium larger than 5 cm, we would place a second
esion that would connect with the superior aspect of the pulmo-
ary vein lesions.
Dr Chitwood. Therefore it is mainly related to the device, is
hat correct?
Dr Lall. Yes.
Dr Chitwood. And I think I will yield my last 2 questions. My
ast question will be this: What percentage of your patients re-
uired a second electrophysiologic study for flutter? Did you have
uch flutter develop after these procedures?
Dr Lall. We did not have any reoperations for atrial flutter.
Dr Chitwood. Even in the catheterization laboratory?
Dr Lall. Correct.
Dr Chitwood. I thank the Association for the opportunity toiscuss this fine article.
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A
CDDr John Stulak (Rochester, Minn). What was your method of
hythm assessment for these patients during their clinical follow-
p? Was it telephone interview, electrocardiogram, Holter moni-
or, etc?
Dr Lall. In the CM III group we did a retrospective follow-up
hrough a mailed questionnaire or telephone interview, as well as
aving contact with either their cardiologist or primary care phy-
ician regarding recurrence of AF. In patients who complained of
rrhythmia recurrence, copies of an electrocardiogram and Holter
onitoring were obtained. In the CM IV group an electrocardio-
ram was obtained at scheduled 1-, 3-, 6-, and 12-month follow-up
ppointments. Our study had 100% follow-up in this group. Pa-
ients unable to return to our clinic were contacted by telephone,
nd electrocardiograms from their referring physicians were ob-
ained. A 24-hour Holter monitor or event recorder was obtained
n each patient with any symptoms or palpitations.
Dr Syed Tasnim Raza (Parkersburg, WV). Dr Lall, I wanted
o congratulate you on a very fine presentation. When Dr Cox
oved from St Louis to Washington, he changed from doing all
ut-and-sew maze procedures to cryoablation, using a long cryo-
blation probe, the procedure he called cryo-maze, and I wanted to
sk, how does your CM IV procedure differ from the cryo-maze
rocedure? My second question is this: you used 2 separate bipolar o
96 The Journal of Thoracic and Cardiovascular Surgery ● FebrF technologies, the Medtronic and the Atricure. Was there any
ifference between the results in those 2, and have you compared
hem?
Thank you very much.
Dr Lall. I am unsure of how the cryo-maze procedure com-
ares with our CM IV procedure.
For your second question, the Atricure device was used for 57
f the 58 patients, and the Medtronic device was used for only 2
atient. We did not look for any difference between the 2 devices.
Dr Craig R. Smith (New York, NY). I am curious how much
verlap there was during the period of the study between the 2
rocedures. You would think that a procedure with such a dramat-
cally reduced crossclamp time would quickly replace its prede-
essor if it seemed even close to equivalent. If there was little
verlap, I would not think you would need to do a propensity
nalysis.
Dr Lall. We no longer do the CM III procedure at Barnes-
ewish. There was no overlap between the 2 procedures. Thus to
ompare these 2 nonrandomized groups, a propensity analysis was
one.
Dr Smith. I understand. I just could not see as much of a
ationale for it if they were really just one procedure following the
ther. Point made.
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